• IMPDH Inhibition Suppresses PEDV Replication via Nucleotide

  2026-07-07

  This study reveals that porcine epidemic diarrhea virus (PEDV) exploits host IMPDH-dependent guanine nucleotide biosynthesis to facilitate its replication. Both genetic silencing and pharmacological inhibition of IMPDH, particularly with Merimepodib (VX-497), significantly impair PEDV propagation, highlighting a host-targeted antiviral strategy relevant for translational virology.

• UK-5099 in Advanced Immunometabolism: Mechanisms and Assay O

  2026-07-07

  Explore the multifaceted roles of UK-5099 (PF-1005023) in immunometabolism research. This article reveals the mechanistic depth, assay design nuances, and translational implications, offering unique insights into mitochondrial pyruvate carrier inhibition.

• Strategic Use of MLN8237 (Alisertib) in Translational Cancer

  2026-07-06

  This thought-leadership article explores the strategic integration of MLN8237 (Alisertib)—a highly selective Aurora A kinase inhibitor—into translational oncology workflows. By synthesizing mechanistic insights, experimental validation, and competitive context, it provides actionable guidance for researchers aiming to advance cancer biology and therapeutic development.

• Cefepime (BMY-28142): Benchmarking Blood-Brain Barrier Effic

  2026-07-06

  Explore Cefepime (BMY-28142) as a research-grade cephalosporin antibiotic with proven efficacy in crossing the blood-brain barrier. This article delivers new insights into benchmarking antibacterial activity for central nervous system infection models and resistance profiling, building upon and extending current research directions.

• Bsa I (RNase-free): Technical Guidance for DNA Manipulation

  2026-07-05

  Bsa I (RNase-free) is a type IIS restriction enzyme designed for precise DNA cleavage while preserving RNA integrity, making it suitable for molecular biology research workflows that require sensitive nucleic acid handling. It should not be used for diagnostic or clinical applications, and is optimized for research settings where RNase-free conditions are essential.

• Liver sEH Drives Osteoclastogenesis via Nrf2 Suppression in

  2026-07-04

  This study uncovers a novel liver-bone regulatory axis in osteoporosis, demonstrating that hepatic soluble epoxide hydrolase (sEH) promotes osteoclast differentiation by suppressing Nrf2 signaling through altered epoxyeicosatrienoic acid metabolism. These findings provide mechanistic insight into redox imbalance in bone disease and highlight new opportunities for targeted intervention.

• Cy3-UTP in Single-Nucleotide RNA Dynamics: From Fluorescence

  2026-07-03

  Explore how Cy3-UTP, a Cy3-modified uridine triphosphate, enables single-nucleotide resolution studies of RNA conformational changes. This article uniquely connects advanced fluorescence labeling with actionable assay design, revealing new frontiers in RNA-protein interaction research.

• 4-Methylumbelliferyl-β-D-Glucopyranoside: Precision in Lysos

  2026-07-03

  4-Methylumbelliferyl-β-D-Glucopyranoside (4-MUG) enables ultra-sensitive, quantitative measurement of β-glucosidase and β-glucocerebrosidase activity in lysosomal research. This article details stepwise experimental workflows, key innovations from recent mRNA-based Gaucher disease models, and practical troubleshooting that set APExBIO's 4-MUG apart for both discovery and translational applications.

• Dextran Microgels Enable Targeted Oral Therapy for Colon Can

  2026-07-02

  This study presents a dual-targeted, orally administered system using dextran microgels to deliver cisplatin/SPION lipid nanotherapeutics directly to colon tumors. The approach enhances local drug accumulation, minimizes systemic exposure, and demonstrates significant tumor inhibition, offering a promising advance for colorectal cancer treatment.

• Iptacopan (LNP023): Precision Control of the Alternative Com

  2026-07-02

  Explore how Iptacopan (LNP023) enables targeted, reversible inhibition of complement factor B for advanced complement activation research. This article offers a distinct, mechanistic insight into assay design and translational modeling with Iptacopan, highlighting novel protocol strategies and practical implications.

• Septin4 Enhances VHL-Mediated HIF-1α Degradation in Cardiomy

  2026-07-01

  The referenced study identifies Septin4 as a facilitator of cardiomyocyte apoptosis under hypoxic conditions by promoting the VHL-mediated degradation of HIF-1α. This mechanistic insight clarifies how mitochondrial proteins intersect with hypoxia signaling, potentially informing new strategies for myocardial ischemia intervention.

• Sodium Phosphate Dibasic: Strategic Buffering for Translatio

  2026-07-01

  Explore how sodium phosphate dibasic (Na2HPO4) shapes reproducibility and data integrity in aquatic toxicity and molecular biology workflows. This thought-leadership article bridges mechanistic insight with strategic guidance, highlighting both cutting-edge evidence and practical protocols for translational researchers, and demonstrates how APExBIO’s high-purity Na2HPO4 raises the bar for assay reliability.

• 3-Deazaneplanocin (DZNep): Precision Epigenetic Modulation i

  2026-06-30

  Explore how 3-Deazaneplanocin (DZNep) drives precise epigenetic modulation and apoptosis induction in cancer models. This article provides a distinct, evidence-backed perspective on DZNep’s mechanistic depth and assay design for oncology research.

• WNT5a/GSK3/β-catenin Axis Regulates FAP Adipogenesis in Musc

  2026-06-30

  This study uncovers the canonical WNT/GSK3/β-catenin axis as a key regulatory mechanism restraining adipogenic differentiation of skeletal muscle fibro/adipogenic progenitors (FAPs). Their findings highlight therapeutic and research opportunities for modulating muscle fat infiltration and regeneration.

• GRE Combination Suppresses Melanogenesis via CREB/MITF Modul

  2026-06-29

  The referenced study demonstrates that a specific combination of glabridin, resveratrol, and ellagic acid (GRE) inhibits melanin synthesis, oxidative stress, and inflammation by targeting the CREB/MITF pathway in melanocytes. These mechanistic insights point to GRE's potential as a safer and more effective tool for pigmentation regulation and for addressing hyperpigmentation disorders.

3711 records 10/248 page Previous Next First page 上5页 678910 下5页 Last page